Journal article
Rivaroxaban with or without aspirin for prevention of cardiovascular disease
Authors
Kruger PC; Eikelboom JW; Yusuf S
Journal
Coronary Artery Disease, Vol. 29, No. 5, pp. 361–365
Publisher
Wolters Kluwer
Publication Date
August 1, 2018
DOI
10.1097/mca.0000000000000605
ISSN
0954-6928
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AspirinBlood CoagulationCardiovascular DiseasesClinical Decision-MakingEvidence-Based MedicineFactor Xa InhibitorsFibrinolytic AgentsHemorrhageHumansPlatelet ActivationPlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsRivaroxabanThrombosisTreatment Outcome